Archive for October, 2013
-
The narrow therapeutic window of ribavirin as an inhibitor of nitric oxide synthesis is broadened by macromolecular prodrugs
Our newest publication, demonstrating how macromolecular prodrugs broaden the therapeutic window of the associated drug, has been published in Biomacromolecules.
